AVAST-M: Adjuvant bevacizumab as treatment for melanoma patients at high risk of recurrence

Autor:	Paul Nathan, Ruth E Board, Neville Davidson, Andrea Marshall, Paul Lorigan, Mark R. Middleton, Charles Kelly, Martin Gore, Janet A. Dunn, Jenny Nobes, Steve Nicholson, Jim Barber, Stephen Houston, Mark Harries, Ernest Marshall, Sarah Danson, Ashita Waterston, Madusha Goonewardena, Philippa Corrie, Maria Marples
Rok vydání:	2013
Předmět:	Oncology Cancer Research medicine.medical_specialty Bevacizumab business.industry medicine.medical_treatment Melanoma medicine.disease Internal medicine Ophthalmology Medicine business Adjuvant medicine.drug
Zdroj:	ResearcherID
ISSN:	1527-7755 0732-183X
DOI:	10.1200/jco.2013.31.15_suppl.lba9000
Popis:	LBA9000 The full, final text of this abstract will be available at abstract.asco.org at 7:30 AM (EDT) on Saturday, June, 1, 2013, and in the Annual Meeting Proceedings online supplement to the June 20, 2013, issue of Journal of Clinical Oncology. Onsite at the Meeting, this abstract will be printed in the Saturday edition of ASCO Daily News.
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_dedup___::35c066acfa8587573632b5b5277a070b https://doi.org/10.1200/jco.2013.31.15_suppl.lba9000 Zobrazit plný text záznamu